Welcome to LookChem.com Sign In|Join Free
  • or
4-fluoro-2-phenoxy-benzoic acid methyl ester is a synthetic organic compound with the chemical formula C15H12FNO3. It is a derivative of benzoic acid, featuring a fluorine atom at the 4-position, a phenoxy group at the 2-position, and a methyl ester group at the carboxylic acid end. 4-fluoro-2-phenoxy-benzoic acid methyl ester is characterized by its potential applications in pharmaceuticals and agrochemicals, where it may serve as an intermediate in the synthesis of various active ingredients. The presence of the fluorine atom can significantly influence the compound's reactivity and physical properties, such as lipophilicity, which can be crucial for its biological activity. The phenoxy group provides a phenolic moiety, which can engage in hydrogen bonding and other interactions within a biological context. The methyl ester group makes the compound more lipophilic and can be hydrolyzed under certain conditions to release the parent benzoic acid, which may be the active form of the compound. Overall, 4-fluoro-2-phenoxy-benzoic acid methyl ester is a versatile chemical entity with potential applications in the development of new drugs and pesticides.

448-20-4

Post Buying Request

448-20-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

448-20-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 448-20-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,4 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 448-20:
(5*4)+(4*4)+(3*8)+(2*2)+(1*0)=64
64 % 10 = 4
So 448-20-4 is a valid CAS Registry Number.

448-20-4Relevant academic research and scientific papers

BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES

-

Page/Page column 226, (2010/06/20)

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

-

Page/Page column 49, (2010/08/07)

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 448-20-4